Background. Sentinel lymph node (SN) biopsy will increasingly replace axillary lymph node
dissection (ALND) for staging in breast cancer. For daily practice, examination of the SN by …

BACKGROUND: Although sentinel lymph node (SLN) biopsy is widely accepted as a
minimally invasive method of nodal staging, failure to identify an SLN mandates a level I/II …

▪ Abstract The standard of care for the evaluation of axillary nodal involvement remains
complete lymph node dissection. Lymphatic mapping and sentinel lymph node (SLN) biopsy …

Abstract Background In 2003, the American Joint Committee on Cancer (AJCC) initiated the
6th edition staging criteria, including pN0 (i+) and pN1mi categories for breast cancer …

Background and methods: This review examines the various methods of detecting occult
breast cancer metastasis in the sentinel lymph node (SLN). The prognostic relevance of …

Sentinel lymph node (SLN) biopsy is a useful way of assessing axillary nodal status and
obviating axillary lymph node dissection (ALND) in patients with node‐negative breast …

Sentinel lymph node biopsy is an important new addition to the surgical management of
patients with breast carcinoma. Sentinel nodes have a higher chance of containing …

BACKGROUND: The need for axillary nodal staging in favorable histologic subtypes of
breast cancer is controversial. METHODS: Patients with clinical stage T1-2, N0 breast …

Objective: To determine if micrometastatic disease in the sentinel lymph node is a predictor
of non-sentinel lymph node (non-SLN) involvement in breast cancer. Summary Background …

Objective To define preliminary guidelines for the use of lymphatic mapping techniques in
patients with breast cancer. Summary Background Data Lymphatic mapping techniques …